Ambagon Therapeutics’ $85 Million Series A Financing

Martina Bellini
Tagged:

Wilson Sonsini Goodrich & Rosati advised Ambagon Therapeutics on the deal.Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, announced an…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now